Literature DB >> 6500366

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.

A S Lok, S J Hadziyannis, I V Weller, M G Karvountzis, J Monjardino, P Karayiannis, L Montano, H C Thomas.   

Abstract

The relationship between the histological diagnosis and serological and tissue markers of HBV replication in 41 Greek and 29 British patients with chronic HBV infection were studied. All the nine Greek and 13 British patients who were HBeAg positive had HBV-DNA in serum and HBcAg expression in the hepatocytes. The majority (73%) of these patients had active liver disease. Forty seven per cent of the Greek and 19% of the British patients who were anti-HBe positive continued to display HBcAg in the liver with or without HBV-DNA detected in serum. All but three of these patients had persistently active liver disease. Continuing inflammatory activity in the liver, however, was also found in 31% of anti-HBe positive patients who had no evidence of HBV replication. In these patients, other factors such as delta agent, NANB viruses, alcohol abuse or an autoimmune reaction initiated by HBV may be contributory.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6500366      PMCID: PMC1432328          DOI: 10.1136/gut.25.11.1283

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants.

Authors:  K Okada; I Kamiyama; M Inomata; M Imai; Y Miyakawa
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

2.  Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers.

Authors:  S Hadziyannis; M A Gerber; C Vissoulis; H Popper
Journal:  Arch Pathol       Date:  1973-11

3.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

4.  A biological role for the major histocompatibility antigens.

Authors:  P C Doherty; R M Zinkernagel
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

5.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

6.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.

Authors:  G Realdi; A Alberti; M Rugge; F Bortolotti; A M Rigoli; F Tremolada; A Ruol
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

7.  Integrator enzyme hypothesis for replication of hepatitis-B virus.

Authors:  S Z Hirschman
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

8.  Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

Authors:  F Gudat; L Bianchi; W Sonnabend; G Thiel; W Aenishaenslin; G A Stalder
Journal:  Lab Invest       Date:  1975-01       Impact factor: 5.662

9.  Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure.

Authors:  H J Alter; L B Seeff; P M Kaplan; V J McAuliffe; E C Wright; J L Gerin; R H Purcell; P V Holland; H J Zimmerman
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2.

Authors:  A McMichael
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  15 in total

1.  Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis.

Authors:  M R Brunetto; M M Giarin; F Oliveri; E Chiaberge; M Baldi; A Alfarano; A Serra; G Saracco; G Verme; H Will
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Study on hepatitis B virus pre-S/S gene mutations of renal tissues in children with hepatitis B virus-associated membranous nephropathy.

Authors:  Se Eun Kim; Yeong Hong Park; Woo Yeong Chung
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

Review 3.  Serological responses to HBV infection.

Authors:  E A Fagan; R Williams
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Progress in hepatitis B: a 30-year journey through three continents.

Authors:  Anna Suk-Fong Lok
Journal:  Hepatology       Date:  2014-05-28       Impact factor: 17.425

6.  Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion.

Authors:  Chia-Ming Chu; Chau-Ting Yeh; Ching-Song Lee; I-Shyan Sheen; Yun-Fan Liaw
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

Review 7.  Lamivudine: in children and adolescents with chronic hepatitis B virus infection.

Authors:  Susan J Keam; Lesley J Scott
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

9.  Detection of hepatitis B virus DNA in chronic carriers by the polymerase chain reaction.

Authors:  C Malavé Lara; M T Gorriño; C Campelo; P Lardelli; E Suñen; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

10.  Detection of hepatitis B virus DNA in human serum by dot hybridization using a biotin-labelled probe.

Authors:  I H Roe; J H Roe; D H Lee
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.